Ronald Blue Trust, Inc. Abb Vie Inc. Transaction History

Ronald Blue Trust, Inc.

$7.98 Billion
Q3 2024

A detailed history of Ronald Blue Trust, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 39,212 shares of ABBV stock, worth $6.73 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

39,212

Previous 27,768 41.21%

Holding current value

$6.73 Million

Previous $4.76 Million 62.6%

% of portfolio

0.1%

Previous 0.07%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$163.84 - $199.33 $1.87 Million - $2.28 Million	11,444 Added 41.21%	39,212 $7.74 Million
Q2 2024 Jul 18, 2024	BUY	$154.79 - $180.76 $440,067 - $513,900	2,843 Added 11.41%	27,768 $4.76 Million
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $72,718 - $82,855	-455 Reduced 1.79%	24,925 $4.54 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $221,123 - $249,036	1,607 Added 6.76%	25,380 $3.78 Million
Q3 2023 Oct 11, 2023	BUY	$133.59 - $154.65 $156,567 - $181,249	1,172 Added 5.19%	23,773 $3.2 Million
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $879,336 - $1.09 Million	-6,636 Reduced 22.7%	22,601 $3.6 Million
Q1 2023 Apr 17, 2023	SELL	$144.61 - $166.54 $52,204 - $60,120	-361 Reduced 1.22%	29,237 $4.73 Million
Q4 2022 Jan 17, 2023	BUY	$138.31 - $165.87 $603,308 - $723,524	4,362 Added 17.28%	29,598 $3.97 Million
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $238,491 - $273,533	1,777 Added 7.57%	25,236 $3.87 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $3.23 Million - $4.1 Million	23,459 New	23,459 $3.8 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.

Account

Ronald Blue Trust, Inc. Abb Vie Inc. Transaction History